GPR30 is thought to be a new membrane-bound estrogen receptor, which differs from the classical nuclear estrogen receptors α and β (ERα and ERβ)[34] and with a disputed role as a functional estrogen receptor in breast cancer cells. Here, ESR2 is linked to breast cancer.